Comprehensive Care for Persons with Diabetes: A Certificate Program

Comprehensive Care for Persons with Diabetes: A Certificate Program

  • Register
    • Non-member - $550
    • Member - $450
    • Resident/Fellow - $350
    • Student - $350

    Continue

Note: This education is not intended to replace or supplant endocrinology board certification. Instead, this is a supplemental educational program for physicians who treat patients with diabetes. It is always recommended that primary management of diabetes is performed by the patient’s board-certified endocrinologist.

The American College of Osteopathic Internists (ACOI) has created a certificate program exploring the many facets of diabetes care and management. Developed through the efforts of endocrinologists and family physicians, this 12-part course encompasses both the clinical aspects of diabetes care as well as the supportive social pieces.

This course features 12 modules, each with a pre- and post-test, as well as a final exam to test your knowledge and competency at the end of the course. The entire course, including the final exam, offers 15.00 AOA Category 1-A CME, 15.00 AMA PRA Category 1 credits, and 15.00 ABIM MOC points for successful course completion. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam.

Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

Learning Objectives
Upon the successful completion of this 12-part course, learners will:

  • Describe the spectrum of diabetes and considerations in special populations to provide personalized care. 
  • Identify patient-centered approaches to support psychosocial concerns and social determinants of health in patients with diabetes. 
  • Recognize approaches to patient engagement for successful approaches to prevention of progression of prediabetes to type 2 diabetes. 
  • Apply medical therapy options of insulin and non-insulin treatments to managing patient cases. 
  • Compare innovative approaches to care delivery with new technology and therapeutic options.

Audience
The target audience for the certificate program is physicians interested in expanding their approaches to diabetes care and management. This course will also be of interest to those responsible for the care of patients with diabetes, primarily nurse practitioners, registered nurses, physician assistants, and pharmacists.

Prices:

  • Non-Member: $550.00
  • Member: $450.00
  • Resident/Fellow: $175.00 (through September 30, 2024)
  • Student: $175.00 (through September 30, 2024)

  • Pre-Assessment: Comprehensive Care for Persons with Diabetes
    Contains 1 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). Thank you for registering for Comprehensive Care for Persons with Diabetes. This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life. Before we begin with education content, please complete this brief survey.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Thank you for registering for Comprehensive Care for Persons with Diabetes. This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    Before we begin with education content, please complete this brief survey.

  • Differentiating the Spectrum of Diabetes
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Identify the classification of diabetes including type 1, type 2, atypical and gestational diabetes. • Describe methods for diagnosis of prediabetes and diabetes. • Apply recommendations for screening for prediabetes and diabetes to patients.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.


    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.


    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Identify the classification of diabetes including type 1, type 2, atypical and gestational diabetes.
    • Describe methods for diagnosis of prediabetes and diabetes.
    • Apply recommendations for screening for prediabetes and diabetes to patients.

    Faculty Disclosures
    Kim Pfotenhauer, DO
    Michigan State University College of Osteopathic Medicine
    East Lansing, MI

    Disclosures: No financial relationships

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Kim Pfotenhauer, DO

    Michigan State University College of Osteopathic Medicine
    East Lansing, MI
    No disclosures

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Prediabetes & Successful Approaches to Prevention
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Define the condition of prediabetes. • Understand the disease burden in our population. • Analyze the progression of glucose impairment to T2D. • Apply the standards for identification of persons with prediabetes. • Examine the data for prediabetes disease intervention. • Create an individualized care plan for each person with prediabetes.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Define the condition of prediabetes.
    • Understand the disease burden in our population.
    • Analyze the progression of glucose impairment to T2D.
    • Apply the standards for identification of persons with prediabetes.
    • Examine the data for prediabetes disease intervention.
    • Create an individualized care plan for each person with prediabetes.

    Faculty Disclosures:
    Kevin T. Miller, DO
    Diabetes and Obesity Care
    Bend, OR

    Disclosures: Advisory Board - Astra Zeneca; Research Funding - Abbott, Pendulum

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Kevin T. Miller, DO

    Diabetes and Obesity Care

    Bend, OR

    Disclosures:

    • Advisory Board; Astra Zeneca
    • Research Funding: Abbott; Pendulum

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Lifestyle Approaches to Type 2 Diabetes
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Outline key lifestyle behaviors (nutrition, physical activity, weight) that play a critical role in the development of Prediabetes (PreD) and Type 2 Diabetes (T2D). • Summarize biobehavioral relationships of these lifestyle factors with PreD and T2D course and outcomes focusing on midlife to late life adults. • Review evidence supporting efficacy and effectiveness of lifestyle modification programs and disease prevention or management. • Recognize barriers and facilitators. • Discuss promising new directions.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Outline key lifestyle behaviors (nutrition, physical activity, weight) that play a critical role in the development of Prediabetes (PreD) and Type 2 Diabetes (T2D).
    • Summarize biobehavioral relationships of these lifestyle factors with PreD and T2D course and outcomes focusing on midlife to late life adults.
    • Review evidence supporting efficacy and effectiveness of lifestyle modification programs and disease prevention or management.
    • Recognize barriers and facilitators.
    • Discuss promising new directions.

    Faculty Disclosures:
    Elizabeth M. Venditti, PhD
    University of Pittsburgh School of Medicine
    Pittsburgh, PA

    Disclosures: Advisory Board - PeopleOne Health

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Elizabeth M. Venditti, PhD

    University of Pittsburgh School of Medicine

    Pittsburgh, PA

    Disclosures:

    • Advisory Board: PeopleOne Health

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Social Determinants of Health
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Apply SDOH to diabetes. • Through patient interactions: • Identify SDOH factors. • Discuss SDOH with patients. • Include SDOH in treatment plans. •Provide patients with supportive resources.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Apply SDOH to diabetes.
    • Through patient interactions:
      • Identify SDOH factors.
      • Discuss SDOH with patients.
      • Include SDOH in treatment plans.
    • Provide patients with supportive resources.

    Faculty Disclosures:
    Jay H. Shubrook, DO, FAAFP, FACOFP
    Touro University
    Vallejo, CA

    Disclosures: Advisory Board - Novo Nordisk, Bayer, Eli Lilly

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Jay H. Shubrook, DO, FAAFP, FACOFP

    Touro University

    Vallejo, CA

    Disclosures:

    • Advisory Board: Novo Nordisk; Bayer; Eli Lilly

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Medical Therapy: Insulin Treatment
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Relate insulin therapy to the 24-hour pattern of endogenous insulin secretion. • Differentiate the pharmacokinetic profiles of action of available short-acting (bolus) and long-acting (basal) insulins. • Interpret the clinical application of insulin concentration U numbers and biosimilar insulins. • Summarize the key steps in optimizing use of basal and bolus insulin in type 2 diabetes mellitus. • Recognize the clinical differences and relative benefits of insulin versus GLP-1 receptor agonist therapy in type 2 diabetes.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Relate insulin therapy to the 24-hour pattern of endogenous insulin secretion.
    • Differentiate the pharmacokinetic profiles of action of available short-acting (bolus) and long-acting (basal) insulins.
    • Interpret the clinical application of insulin concentration U numbers and biosimilar insulins.
    • Summarize the key steps in optimizing use of basal and bolus insulin in type 2 diabetes mellitus.
    • Recognize the clinical differences and relative benefits of insulin versus GLP-1 receptor agonist therapy in type 2 diabetes.

    Faculty Disclosures:
    John L. Leahy, MD
    University of Vermont
    Burlington, VT

    Disclosures: Advisory Board - Merck & Co, Hillbloom Foundation

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    John L. Leahy, MD

    University of Vermont

    Burlington, VT

    Disclosures: Advisory Board - Merck & Co, Hillbloom Foundation

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Medical Therapy: Non-Insulin Treatment
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Identify non-insulin antihyperglycemic agents presently available for treatment of individuals with type 2 diabetes. • Compare and contrast benefits and risks of non-insulin antihyperglycemic agents including those not specifically related to glucose lowering. • Select appropriate antihyperglycemic agents for individual patients based on matching characteristics of medications and patients’ needs.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Identify non-insulin antihyperglycemic agents presently available for treatment of individuals with type 2 diabetes.
    • Compare and contrast benefits and risks of non-insulin antihyperglycemic agents including those not specifically related to glucose lowering.
    • Select appropriate antihyperglycemic agents for individual patients based on matching characteristics of medications and patients’ needs.

    Faculty Disclosures:
    Lawrence Blonde, MD, FACP, MACE
    Ochsner Medical Center
    New Orleans, LA

    Disclosures: Consultant - Corcept Therapeutics, Gilead Sciences, Janssen Pharmaceuticals, Lyndra Therapeutics, Merck, Novo Nordisk, Salix Pharmaceuticals, Sanofi.

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Lawrence Blonde, MD, FACP, MACE

    Ochsner Medical Center

    New Orleans, LA

    Disclosures:

    • Consultant: Corcept Therapeutics; 
    • Gilead Sciences, Inc.; 
    • Janssen Pharmaceuticals, Inc; 
    • Lyndra Therapeutics; Merck; Novo Nordisk; 
    • Salix Pharmaceuticals; Sanofi

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Maximizing Patient Engagement
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Identify essential diabetes disease state elements as a foundation. • Prescribe science-based individualized care plans. • Create an effective diabetes care team to improve clinic workflow, coordination and facilitate engagement. • Conduct the “Diabetes Only” visit to reduce therapeutic inertia and optimal timeframe for scheduling follow-up visits based on A1C and medication changes. • Understand virtual care to facilitate touch points and more convenient interactions.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Identify essential diabetes disease state elements as a foundation.
    • Prescribe science-based individualized care plans.
    • Create an effective diabetes care team to improve clinic workflow, coordination and facilitate engagement.
    • Conduct the “Diabetes Only” visit to reduce therapeutic inertia and optimal timeframe for scheduling follow-up visits based on A1C and medication changes.
    • Understand virtual care to facilitate touch points and more convenient interactions.

    Faculty Disclosures:
    Eden M. Miller, DO
    Diabetes and Obesity Care
    Bend, OR

    Disclosures: Advisory Board - Abbott, Lilly, Novo Nordisk, Boehringer Ingelheim, Merck, Bayer, Pendulum.

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Eden M. Miller, DO

    Diabetes and Obesity Care

    Bend, OR

    Disclosures:

    • Advisory Board: Abbott; Lilly USA; Novo Nordisk; Boehringer Ingelheim; Merck; Bayer; Pendulum

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Use of Technology to Manage Diabetes
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Define the limits of the A1C and BGM. • Describe the various types of technology available to manage people with diabetes. • Explain how to choose the right technology for each individual.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Define the limits of the A1C and BGM.
    • Describe the various types of technology available to manage people with diabetes.
    • Explain how to choose the right technology for each individual.

    Faculty Disclosures:
    Anne L. Peters, MD
    University of Southern California
    Los Angeles, CA

    Disclosures: Advisory Board - Abbott, Astra Zeneca, Lilly, Medscape, Novo Nodisk, Zealand, Vertex

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Anne L. Peters, MD

    University of Southern California

    Los Angeles, CA

    Disclosures:

    • Advisory Board: Abbott Diabetes Care; Astra Zeneca; Lilly; Medscape; Novo Nordisk; Zealand; Vertex

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

  • Innovative Approaches to Care Delivery
    Contains 3 Component(s)

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care). By the end of this module, you should be able to: • Identify different approaches to care delivery. • Understand methods that have worked in group visits, case studies, and remote visits. • Analyze effective two-way email communications. • Recognize hurdles for primary care physicians.

    Note: This education in not intended for any type of board certification but is instead a supplemental education for physicians that care for patients with diabetes (not to replace the patient's endocrinologist who is managing that patient's diabetes care).

    Introduction and Instructions

    Thank you for your interest in Comprehensive Care for Persons with Diabetes: A Certificate Program! This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life.

    For each module, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take about 75 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency.

    You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources.

    The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME hours available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Partial credit will not be awarded.

    Course Outline:

    • Pre-test for module (repeat for modules 1-12)
    • Interactive module (repeat for modules 1-12)
    • Post-test for module (repeat for modules 1-12)
    • Final exam (must achieve 70% or higher to obtain certificate)
    • Certificate and resources

    Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

    By the end of this module, you should be able to:

    • Identify different approaches to care delivery.
    • Understand methods that have worked in group visits, case studies, and remote visits.
    • Analyze effective two-way email communications.
    • Recognize hurdles for primary care physicians.

    Faculty Disclosures:
    Leonard R. Bertheau, DO
    Adventist Health
    Portland, OR

    Disclosures: Speaker - Medtronic

    To ask a question of this presenter please send an email to elearning@acofp.org with the subject line indicating both the presenter and module names.

    Leonard Bertheau, DO

    Adventist Health

    Portland, OR

    Disclosures:

    • Speaker: Medtronic

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

    The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

    ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
    This activity is not supported by educational grant(s) or other funds from any commercial supporter.

Statement of Independence
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

This program is sponsored by ACOFP for educational purposes only. The material presented is not intended to represent the sole or best medical interventions for the discussed diagnoses, but rather is intended to present the opinions of the authors or presenters that may be helpful to other practitioners. Attendees participating in this medical education program do so with the full knowledge that they waive any claim they may have against ACOFP for reliance on any information presented during these educational activities.

Disclaimers
The American College of Osteopathic Family Physicians (ACOFP) online education is an educational resource and as such does not define a standard of care, nor is it intended to dictate an exclusive course of treatment or procedure to be followed. It presents methods and techniques of clinical practice that are acceptable and used by recognized authorities, for consideration by licensed physicians and healthcare providers to incorporate into their practice. Variations of practice, taking into account the needs of the individual patient, resources, and limitation unique to the institution or type of practice, may be appropriate.

The statements and opinions expressed within this educational program are those of the faculty and not necessarily those of the ACOFP. The ACOFP disclaims any responsibility and/or liability for such information.

Faculty Disclosure Policies
It is the policy of the American College of Osteopathic Family Physicians (ACOFP) to ensure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any ACOFP sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following faculty reported relevant financial relationships: Kevin T. Miller, DO: Advisory Board - Astra Zeneca; Research Funding - Abbott, Pendulum. Elizabeth M. Venditti, PhD: Advisory Board - PeopleOne Health. Jay H. Shubrook, DO, FAAFP, FACOFP: Advisory Board - Novo Nordisk, Bayer, Eli Lilly. John L. Leahy, MD: Advisory Board - Merck & Co, Hillbloom Foundation. Lawrence Blonde, MD, FACP, MACE: Consultant - Corcept Therapeutics, Gilead Sciences, Janssen Pharmaceuticals, Lyndra Therapeutics, Merck, Novo Nordisk, Salix Pharmaceuticals, Sanofi. Eden M. Miller, DO: Advisory Board - Abbott, Lilly, Novo Nordisk, Boehringer Ingelheim, Merck, Bayer, Pendulum. Anne L. Peters, MD: Advisory Board - Abbott, Astra Zeneca, Lilly, Medscape, Novo Nodisk, Zealand, Vertex. Leonard R. Bertheau, DO: Speaker - Medtronic. Davida F. Kruger, MSN, APN-BC, BC-ADM: Speaker - Novo Nordisk, Eli Lilly, Abbott, Dexcom, Xeris, Astra Zeneca, Sanofi; Advisor - Novo Nordisk, Eli Lilly, Abbott, Sanofi; Stock Options - Pendulum; Research Funding - Novo Nordisk, Dexcom, Abbott. Mark E. Molitch, MD: Research Funding - Bayer, Novartis; Consultant - Janssen, Merck, Pfizer.

The following faculty reported no relevant financial relationships: Kim Pfotenhauer, DO; Robert S. Gotfried, DO, FAAFP

The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.

The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is not supported by educational grant(s) or other funds from any commercial supporter.

image
Kim Pfotenhauer, DO
Michigan State University College of Osteopathic Medicine
East Lansing, MI
• No disclosures		image
Kevin T. Miller, DO
Diabetes and Obesity Care
Bend, OR
Disclosures:
• Advisory Board; Astra Zeneca Research Funding: Abbott; Pendulum
image
Elizabeth M. Venditti, PhD
University of Pittsburgh School of Medicine
Pittsburgh, PA
Disclosures:
• Advisory Board: PeopleOne Health		image
Jay H. Shubrook, DO, FAAFP, FACOFP
Touro University
Vallejo, CA
Disclosures:
• Advisory Board: Novo Nordisk; Bayer; Eli Lilly
image
John L. Leahy, MD
University of Vermont
Burlington, VT
Disclosures:
• Advisory Board: Merck & Co.; Hillbloom Foundationt		image
Lawrence Blonde, MD, FACP, MACE
Ochsner Medical Center
New Orleans, LA
Disclosures:
• Consultant: Corcept Therapeutics; 
• Gilead Sciences, Inc.; 
• Janssen Pharmaceuticals, Inc; 
• Lyndra Therapeutics; Merck; Novo Nordisk; 
• Salix Pharmaceuticals; Sanofi
image
Eden M. Miller, DO
Diabetes and Obesity Care
Bend, OR
Disclosures:
• Advisory Board: Abbott; Lilly USA; Novo Nordisk; Boehringer Ingelheim; Merck; Bayer; Pendulum		image
Anne L. Peters, MD
University of Southern California
Los Angeles, CA
Disclosures:
• Advisory Board: Abbott Diabetes Care; Astra Zeneca; Lilly; Medscape; Novo Nordisk; Zealand; Vertex
image
Leonard R. Bertheau, DO
Adventist Health
Portland, OR
Disclosures:
• Speaker: Medtronic		image
Davida F. Kruger, MSN, APN-BC,BC-ADM
Henry Ford Health System
Detroit, MI
Disclosures: 
• Speaker: Novo-Nordisk; Eli Lilly; Abbott Diabetes; Dexcom; Xeris; AstraZeneca; Sanofi
• Advisor: Novo-Nordisk; Eli Lilly; Abbott Diabetes; Sanofi
• Stock Options: Pendulum
• Research Funding: Novo Nordisk; Dexcom; Abbott Diabetes
image
Robert S. Gotfried, DO, FAAFP
Ohio State University Wexner Medical Center
Columbus, OH
No disclosures

image
Mark E. Molitch, MD
Northwestern University Feinberg School of Medicine
Chicago, IL
Disclosures:
• Research Funding: Bayer; Novartis
• Consultant: Janssen; Merck; Pfizer

Accreditation Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the American College of Osteopathic Internists. The Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians.

image

AMA PRA Category 1 Credit

The American College of Osteopathic Internists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ACOI designates this course for a maximum of 15.00 AMA PRA Category 1™ Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field. Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

AOA Category 1-A Credit

The American College of Osteopathic Internists (ACOI) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOI designates this program for a maximum number of 15.00 AOA Category 1-A credits and will report CME with the extent of the physician’s participation in this activity. This program is sponsored by ACOI for educational purposes only.

image

Maintenance of Certification (MOC) - if eligible 

Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 15.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

 For questions about content or obtaining CME credit, please contact the ACOI at education@acoi.org.